Status:
UNKNOWN
Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt
Lead Sponsor:
Services Institute of Medical Sciences, Pakistan
Conditions:
Thyroid Dysfunction
Eligibility:
All Genders
18-60 years
Brief Summary
Thyroxin a vital hormone for life lot of body functions depend on proper functioning on pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them containing two iodin...
Detailed Description
All patients presenting to endocrine clinic fulfilling inclusion and exclusion criteria will be recruited. They will be examined, their vitals including blood pressure pulse will be noted, thyroid cli...
Eligibility Criteria
Inclusion
- All patients presenting with biochemical hyperthyroidism
- Who are taking Iodinated salt.
- Treatment naïve patients
- Both genders included
- All patients who can give consent (18-60 years)
Exclusion
- 1\) Pregnant females 2) Lactating mothers
- \-
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04809454
Start Date
October 1 2021
End Date
March 1 2022
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mehwish Iftikhar
Lahore, Punjab Province, Pakistan, 54000